The Headline Grabbers

5-Prime | The Headline Grabbers This year's science newsmakers, besides comparative genomics and systems biology, include ... McSequence Remarkably, scientists completed the genomic sequence of the coronavirus responsible for the SARS pandemic less than two months after it was first identified. "We never had a disease [that] was so much into the public news," says Bhagirath Singh, scientific director of the Canadian Institute for Health Research's Institute of Infection and Immunity. He

Written byMaria Anderson
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

McSequence Remarkably, scientists completed the genomic sequence of the coronavirus responsible for the SARS pandemic less than two months after it was first identified. "We never had a disease [that] was so much into the public news," says Bhagirath Singh, scientific director of the Canadian Institute for Health Research's Institute of Infection and Immunity. He says that genomic information allowed public health officials to identify treatment options more quickly.

Publications made public In September, the Nature Publishing Group revised its policy on conflicts of interest disclosure to include authors of review articles after it was disclosed that one author, Charles B. Nemeroff of The Emory University School of Medicine, wrote, in part, about three products to which he had financial ties. The Public Library of Science published the inaugural issue of PLoS Biology in October, and BioMed Central, an open-access publisher and a partner of The Scientist, received official UK ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies